HomeInsightsStock Comparison

Kimia Biosciences Ltd vs Rekvina Labs Ltd Stock Comparison

Kimia Biosciences Ltd vs Rekvina Labs Ltd Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

  • The Latest Trading Price of Kimia Biosciences Ltd is ₹ 35.34 as of 04 May 09:53 . The P/E Ratio of Kimia Biosciences Ltd changed from 35.1 on March 2021 to 20.9 on March 2025 . This represents a CAGR of -9.85% over 5 yearsThe P/E Ratio of Rekvina Labs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Kimia Biosciences Ltd changed from ₹ 179.55 crore on March 2021 to ₹ 201.13 crore on March 2025 . This represents a CAGR of 2.30% over 5 yearsThe Market Cap of Rekvina Labs Ltd changed from ₹ 2.39 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The revenue of Kimia Biosciences Ltd for the Dec '25 is ₹ 30.2 crore as compare to the Sep '25 revenue of ₹ 33.67 crore. This represent the decline of -10.31% The revenue of Rekvina Labs Ltd for the Dec '25 is ₹ 0.35 crore as compare to the Sep '25 revenue of ₹ 0.2 crore. This represent the growth of 75% The ebitda of Kimia Biosciences Ltd for the Dec '25 is ₹ 6.65 crore as compare to the Sep '25 ebitda of ₹ 2.19 crore. This represent the growth of 203.65% The ebitda of Rekvina Labs Ltd for the Dec '25 is ₹ -0.12 crore as compare to the Sep '25 ebitda of ₹ -0.03 crore. This represent the growth of 300% The net profit of Kimia Biosciences Ltd changed from ₹ 1.44 crore to ₹ 5.44 crore over 7 quarters. This represents a CAGR of 113.72% The net profit of Rekvina Labs Ltd changed from ₹ -0.07 crore to ₹ -0.12 crore over 6 quarters. This represents a CAGR of 43.24% The Dividend Payout of Kimia Biosciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Rekvina Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Kimia Biosciences Ltd

  • Kimia Biosciences Limited, formerly known Laurel Organics Limited was incorporated in September, 1993.
  • The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana.
  • The name of the Company was changed from 'Laurel Organics Limited' to 'Kimia Biosciences Limited' w.e..f 4 January, 2019.
  • Since then, it engages in the business of Pharmaceutical products. The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr.
  • It came out with a public issue in Feb.'95 to part-finance the project.

About Rekvina Labs Ltd

  • Rekvina Labs Limited was incorporated on 1st November 1988.
  • From a small domestic company at inception in middle of 80's, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of Rs 20 Crore.
  • It is registered in England and Wales as a Public Limited Company.
  • The Company is a Quality producer of Pharmaceutical formulations for its customer as per their specific requirements.
  • It provide contract research and manufacturing services to customers. The Company is mainly engaged in manufacturing and marketing of pharmaceutical products.

FAQs for the comparison of Kimia Biosciences Ltd and Rekvina Labs Ltd

Which company has a larger market capitalization, Kimia Biosciences Ltd or Rekvina Labs Ltd?

Market cap of Kimia Biosciences Ltd is 166 Cr while Market cap of Rekvina Labs Ltd is 26 Cr

What are the key factors driving the stock performance of Kimia Biosciences Ltd and Rekvina Labs Ltd?

The stock performance of Kimia Biosciences Ltd and Rekvina Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kimia Biosciences Ltd and Rekvina Labs Ltd?

As of May 4, 2026, the Kimia Biosciences Ltd stock price is INR ₹35.21. On the other hand, Rekvina Labs Ltd stock price is INR ₹43.3.

How do dividend payouts of Kimia Biosciences Ltd and Rekvina Labs Ltd compare?

To compare the dividend payouts of Kimia Biosciences Ltd and Rekvina Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions